Envestnet Asset Management »

Abcellera Biologics shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $60k 23k 2.60
2024-06-30 $44k 15k 2.96
2024-03-31 $64k 14k 4.53
2023-09-30 $54k 12k 4.60

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds Value Etf (VTV)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)

View all positions for Envestnet Asset Management

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Baillie Gifford & Co
Ing Investment Management
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
BlackRock
Renaissance Technologies
Tang Capital Management
Federated Investors
Two Sigma Investments
Guardian Capital Advisors
Two Sigma Advisers
Citadel Advisors
Novo A/S

View all funds holding Abcellera Biologics